With a $35.3 billion market value, Baxter International Inc (NYSE:BAX) ranks in the top 10% of its industry group, Health Care Equipment & Supplies, and in the top decile of sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the stock's current Portfolio Grader score places it 5 among the 164 companies in this industry group, putting it in the top decile; among the sector leaders with a ranking of 11 among the 785 companies in the sector, and number 94 in the nearly 5,000 company Portfolio Grader universe.

Currently, Baxter International Inc (NYSE:BAX) has a Strong Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The shares have been upgraded from a Buy to a Strong Buy in the last week.

With a $34.6 billion market value, Baxter International Inc (NYSE:BAX) ranks in the top 10% of its industry group, Health Care Equipment & Supplies, and in the top 10% of its sector group, Health Care, in market value. From the prospective of investment attractiveness, the stock's Portfolio Grader ranking places it 28 among the 163 companies in this industry group, putting in the top quartile; in the top decile of the sector with a ranking of 67 among the 782 companies in the sector, and number 574 in the nearly 5,000 company Portfolio Grader universe.

Portfolio Grader currently ranks Baxter International Inc (NYSE:BAX) a Buy. The methods for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier researches and ranks nearly 5,000 stocks each week. BAX has maintained this ranking for 10 months.

The current recommendation of Buy for Baxter International Inc (NYSE:BAX) is computed using the approach of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 9 months.